Keam, B., Lee, J. L., Lee, K., Kim, C., Lim, H., Jo, H., Kang, H. (2026). First-in-human phase 1 dose escalation and expansion study of PIN-5018, a CK1α-selective molecular glue degrader, in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3168